Oncogenic PIK3CA corrupts growth factor signaling specificity

Technical limitations have prevented understanding of how growth factor signals are encoded in distinct activity patterns of the phosphoinositide 3-kinase (PI3K)/AKT pathway, and how this is altered by oncogenic pathway mutations. We introduce a kinetic, single-cell framework for precise calculation...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Molecular systems biology 2024-12
Hauptverfasser: Madsen, Ralitsa R, Le Marois, Alix, Mruk, Oliwia N, Voliotis, Margaritis, Yin, Shaozhen, Sufi, Jahangir, Qin, Xiao, Zhao, Salome J, Gorczynska, Julia, Morelli, Daniele, Davidson, Lindsay, Sahai, Erik, Korolchuk, Viktor I, Tape, Christopher J, Vanhaesebroeck, Bart
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Technical limitations have prevented understanding of how growth factor signals are encoded in distinct activity patterns of the phosphoinositide 3-kinase (PI3K)/AKT pathway, and how this is altered by oncogenic pathway mutations. We introduce a kinetic, single-cell framework for precise calculations of PI3K-specific information transfer for different growth factors. This features live-cell imaging of PI3K/AKT activity reporters and multiplexed CyTOF measurements of PI3K/AKT and RAS/ERK signaling markers over time. Using this framework, we found that the PIK3CA oncogene was not a simple, constitutive activator of the pathway as often presented. Dose-dependent expression of PIK3CA in human cervical cancer and induced pluripotent stem cells corrupted the fidelity of growth factor-induced information transfer, with preferential amplification of epidermal growth factor receptor (EGFR) signaling responses compared to insulin-like growth factor 1 (IGF1) and insulin receptor signaling. PIK3CA did not only shift these responses to a higher mean but also enhanced signaling heterogeneity. We conclude that oncogenic PIK3CA corrupts information transfer in a growth factor-dependent manner and suggest new opportunities for tuning of receptor-specific PI3K pathway outputs for therapeutic benefit.
ISSN:1744-4292
1744-4292
DOI:10.1038/s44320-024-00078-x